NIH-funded research Fellowship grant

How axolotls regenerate their limbs using retinoic acid

Official title: Epigenetic regulation of the regenerating axolotl forelimb's proximodistal axis by retinoic acid

Funded at Northeastern University · NIH-10997839 · Data updated 2026-11-12

This study is looking into how axolotls can regrow their limbs without any scars, focusing on a substance called retinoic acid that helps control how cells behave, and it hopes to find out how this knowledge could help improve healing in humans.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionNortheastern University
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 6, 2024
Project endSeptember 5, 2026
Funding year2024
Award (this year)$48,974
NIH project number1F31HD116512-01
Project IDNIH-10997839 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals interested in regenerative therapies or those with conditions that impair healing.

Less likely to help

Patients with conditions unrelated to regeneration or those not seeking innovative healing methods may not benefit from this research.

What this research studies

This research investigates the mechanisms behind the axolotl's remarkable ability to regenerate limbs without scarring. It focuses on the role of retinoic acid, a substance that influences cell behavior, in guiding the regeneration process. By examining how retinoic acid affects gene expression and cellular patterns, the study aims to uncover the genetic factors that enable precise limb regeneration. This could provide insights into how similar processes might be applied to human medicine.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in regenerative medicine, potentially improving healing and regeneration in humans.

How similar studies have gone: While the axolotl's regenerative capabilities have been studied, this specific approach using retinoic acid is relatively novel and has not been extensively tested in similar contexts.

Where this research is happening

  • Northeastern University
    Boston, United States
    Active

Researchers

  • Principal investigator: Miller, Melissa Nanette — Northeastern University
  • Study coordinator: Miller, Melissa Nanette

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.